本文へスキップ

Israel Health Ministry Warns G-Slim Contains 53.8 mg of Banned Sibutramine

Courtroom-sketch editorial illustration of a binocular compound microscope from a 2023 photograph, with branding omitted; symbolic laboratory equipment, not the facility or experiment reported.
AI courtroom sketch of a binocular compound microscope from a 2023 photograph, with branding omitted; symbolic laboratory equipment, not the facility or experiment reported. Adapted from the credited reference. A Binocular Microscope.jpg — Suneksiriaaron; CC0.

Israel's Health Ministry warned consumers not to use G-Slim, a weight-loss product it says is not approved in Israel. Laboratory testing found 53.8 mg of sibutramine in each capsule, more than three times the amount in a similar product previously prohibited. The ministry said a young man was recently hospitalized with chest pain and a rapid heartbeat after taking G-Slim. No registered Israeli product contains sibutramine. The ministry warned of risks including high blood pressure, heart attack, stroke, psychiatric disorders and life-threatening harm.

出典

一次資料:1

関連記事

  1. マゲン・ダビド・アドム、ヨムキプール期間にイスラエル全国で3322人を救護
  2. Nigeria Discloses Ebonyi Meth Lab Raid and Mexican Suspect’s Arrest
  3. Fiji Declares HIV Outbreak a National Crisis as 2025 Diagnoses Reach 2,016
  4. Bangladesh Reports 1,002 Measles and Suspected-Case Deaths Since March
  5. New Zealand Makes Cervical Screening Free for Ages 25–69 From March 2027

問題が発生しました

操作を完了できませんでした。接続を確認して、もう一度お試しください。